Famotidine

🧮 Dose calculator

Peptic ulcer disease · Regimen source: FDA Famotidine susp · 2.2, Table 2

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Famotidine susp · 8.1

  “Risk Summary Available data with H 2 -receptor antagonists, including famotidine, in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Famotidine susp · 8.2

  “Risk Summary There are limited data available on the presence of famotidine in human breast milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Famotidine susp · 8.4

  “Peptic Ulcer Disease and GERD With or Without Esophagitis and Ulcerations Pediatric Patients 1 Year to Less Than 17 Years of Age The safety and effectiveness of famotidine for oral suspension have been established in pediatric patients 1 year to less than 17 years of age for the treatment of peptic ulcer disease and …”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Famotidine susp · 8.5

  “In postmarketing experience, CNS adverse reactions have been reported in elderly patients with and without renal impairment receiving famotidine [see Warnings and Precautions (5.1) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.